ARCHIVES

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

This article is from The Cancer Letter archive.

Vol. 19 No. 06 | February 5, 1993

Download PDF Visit The Full Archive

Related Articles

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

Henderson Heads HHS Preparedness Office; NCI Awards $22M Southern Cohort Study.

November 9, 2001

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

DeVita takes Over As NCI Acing Director; Search Begins For New Permanent Chief

January 4, 1980